Sources | Names Used |
---|---|
CTRPv2 | navitoclax:piperlongumine (1:1 mol/mol) |
PharmacoGx | navitoclax:piperlongumine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ARHGAP33 | CTRPv2 | pan-cancer | AAC | 0.31 | 3e-17 |
mRNA | ZNF737 | CTRPv2 | pan-cancer | AAC | 0.28 | 1e-14 |
mRNA | PRR36 | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-14 |
mRNA | SMAD4 | CTRPv2 | pan-cancer | AAC | 0.29 | 2e-14 |
mRNA | RP11-729L2.2 | CTRPv2 | pan-cancer | AAC | 0.3 | 2e-14 |
mRNA | VPS4B | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-14 |
mRNA | GRIK5 | CTRPv2 | pan-cancer | AAC | 0.27 | 6e-14 |
mRNA | CELF4 | CTRPv2 | pan-cancer | AAC | 0.27 | 7e-14 |
mRNA | SBK1 | CTRPv2 | pan-cancer | AAC | 0.28 | 7e-14 |
mRNA | WDR7 | CTRPv2 | pan-cancer | AAC | 0.29 | 2e-13 |